DaVita(DVA)

Search documents
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know
ZACKS· 2025-02-05 00:05
In the latest trading session, DaVita HealthCare (DVA) closed at $177.35, marking a +0.16% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.72% for the day. Elsewhere, the Dow gained 0.3%, while the tech-heavy Nasdaq added 1.35%.The kidney dialysis provider's stock has climbed by 16.85% in the past month, exceeding the Medical sector's gain of 4.51% and the S&P 500's gain of 1.02%.Investors will be eagerly watching for the performance of DaVita HealthCare in its ...
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call
Prnewswire· 2025-01-30 16:55
DENVER, Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Thursday, February 13, 2025Starting at 5:00 p.m. ESTWebcast can be accessed using this link Dial in num ...
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note
ZACKS· 2025-01-30 00:05
DaVita HealthCare (DVA) closed the most recent trading day at $173.77, moving +0.32% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.47%. On the other hand, the Dow registered a loss of 0.31%, and the technology-centric Nasdaq decreased by 0.51%.Coming into today, shares of the kidney dialysis provider had gained 15.82% in the past month. In that same time, the Medical sector gained 3.2%, while the S&P 500 gained 1.67%.Analysts and investors alike wi ...
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why
ZACKS· 2025-01-29 18:01
Investors might want to bet on DaVita HealthCare (DVA) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a ch ...
Sell Nvidia, Buy This Stock
ZACKS· 2025-01-27 19:20
Big things happened this weekend.In a calculated move, a Chinese AI company released its newest large-language model (LLM), on the same day as the presidential inauguration. Though it took a week for most market participants to take notice, all are now paying attention. DeepSeek, the latest contender in the AI landscape, has made waves by developing an equally powerful algorithm at a fraction of the cost—and it’s open-source. The implications of this are quite significant, as is evident from the price actio ...
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider
ZACKS· 2025-01-24 00:20
In the latest trading session, DaVita HealthCare (DVA) closed at $169.90, marking a +0.86% move from the previous day. This move outpaced the S&P 500's daily gain of 0.53%. Meanwhile, the Dow gained 0.93%, and the Nasdaq, a tech-heavy index, added 0.22%.Shares of the kidney dialysis provider have appreciated by 8.64% over the course of the past month, outperforming the Medical sector's gain of 1.49% and the S&P 500's gain of 2.69%.The investment community will be paying close attention to the earnings perfo ...
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
ZACKS· 2025-01-17 08:46
For Immediate ReleaseChicago, IL – January 17, 2025 – Today, Zacks Equity Research Equity Quest Diagnostics Inc. (DGX) , DaVita Inc. (DVA) , Option Care Health, Inc. (OPCH) and Addus HomeCare Corp. (ADUS) .Industry: Outpatient and Home HealthcareLink: https://www.zacks.com/commentary/2398152/4-stocks-to-monitor-in-a-dynamic-outpatient-home-health-industryThe Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, t ...
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note
ZACKS· 2025-01-16 00:21
In the latest trading session, DaVita HealthCare (DVA) closed at $162.36, marking a +0.22% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.83%. Elsewhere, the Dow saw an upswing of 1.65%, while the tech-heavy Nasdaq appreciated by 2.45%.Shares of the kidney dialysis provider witnessed a gain of 9.78% over the previous month, beating the performance of the Medical sector with its loss of 3.48% and the S&P 500's loss of 3.31%.The investment community will be close ...
DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health
Prnewswire· 2025-01-15 14:05
DENVER, Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the healthcare system. By fostering an inclusive, mission-driven workforce and building strong community partnerships, DaVita is helping empower th ...
DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires
Prnewswire· 2025-01-09 16:00
LOS ANGELES, Jan. 9, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California. DaVita's emergency response plan includes: Accounting for patients and teammates (employees), assessing facilities in the affected areas and identifying safe shelters. Transferring patients to centers that can safely provide dialysis treatment. Providing patients with relevant medical information—including prescription, ...